CCG 0933--MERCAPTOPURINE FOLLOWED BY CYTOSINE ARABINOSIDE IN CHILDREN

CCG 0933--儿童中先用巯基嘌呤，然后用阿糖胞苷

• 批准号: 6116894
• 负责人: BEVERLY LANGE
• 金额: $ 2.47万
• 依托单位: CHILDREN'S HOSP OF PHILADELPHIA
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6116894
• 关键词: clinical research; cytosine arabinoside; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; neoplasm /cancer remission /regression; outcomes research; pediatric neoplasm /cancer; pediatric pharmacology; thiopurine

This is a multicenter phase I-II trial supported by the NIH through the Children's Cancer Group Phase I grant. Four children have been treated at The Children's Hospital of Philadelphia: two have had complete responses and two have had a mixed or MTD has not been reached.

这是一项由 NIH 通过 NIH 支持的多中心 I-II 期试验 儿童癌症组第一期资助。四名儿童已在医院接受治疗 费城儿童医院：两家已得到完整答复 并且两个已经混合或者MTD尚未达到。